Literature DB >> 19398767

Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months.

Andreas Scherer1, Wilfried Gwinner, Michael Mengel, Torsten Kirsch, Friedrich Raulf, Joseph D Szustakowski, Nicole Hartmann, Frank Staedtler, Guenter Engel, Jochen Klupp, Alexander Korn, Jeanne Kehren, Hermann Haller.   

Abstract

BACKGROUND: Interstitial fibrosis and tubular atrophy (IF/TA) in renal transplants are the major morphological correlates of progressive graft deterioration. Early diagnosis of IF/TA is a pre-requisite for a timely therapeutic intervention in patients at risk. To evaluate events occurring before the overt onset of IF/TA, gene expression profiling of 3-month protocol biopsies from patients with IF/TA was performed in a patient group (n = 8) who developed mild IF/TA [chronic allograft nephropathy (CAN) grade I, by the Banff scoring system] in the subsequent 6-month protocol biopsy ('progressors'), and in 12 patients without IF/TA at 6 months ('non-progressors').
METHODS: RNA was extracted, labelled and hybridized to human specific genome wide DNA microarrays. Normalized data were subjected to gene-centric and pathway-centric statistical methods.
RESULTS: Compared to the non-progressors, the 3-month biopsies of the progressor group showed overexpression of several genes that are important in the T- and B-cell activation and immune response. Genes involved in pro-fibrotic processes were identified in the biopsies of the progressors that preceded the observed IF/TA at 6 months. Furthermore, several genes with transporter and metabolic functions were underrepresented in the progressors in the 3-month biopsies.
CONCLUSION: Gene expression profiling of early protocol biopsies identified changes in the transcriptome of grafts, which may be important for the development of IF/TA. Such early detection of transcriptome changes can facilitate the identification of patients at risk shifting the intervention time point well before the histological diagnosis of irreversible IF/TA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398767     DOI: 10.1093/ndt/gfp183

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  21 in total

1.  Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis.

Authors:  Dany Anglicheau; Thangamani Muthukumar; Aurélie Hummel; Ruchuang Ding; Vijay K Sharma; Darshana Dadhania; Surya V Seshan; Joseph E Schwartz; Manikkam Suthanthiran
Journal:  Transplantation       Date:  2012-06-15       Impact factor: 4.939

2.  Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys.

Authors:  Shahrooz S Kelishadi; Agnes M Azimzadeh; Tianshu Zhang; Tiffany Stoddard; Emily Welty; Christopher Avon; Mitch Higuchi; Amal Laaris; Xiang-Fei Cheng; Christine McMahon; Richard N Pierson
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

3.  Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes.

Authors:  Maarten Naesens; Purvesh Khatri; Li Li; Tara K Sigdel; Matthew J Vitalone; Rong Chen; Atul J Butte; Oscar Salvatierra; Minnie M Sarwal
Journal:  Kidney Int       Date:  2011-08-31       Impact factor: 10.612

4.  Fibrosis with inflammation at one year predicts transplant functional decline.

Authors:  Walter D Park; Matthew D Griffin; Lynn D Cornell; Fernando G Cosio; Mark D Stegall
Journal:  J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 10.121

Review 5.  Molecular pathways involved in loss of graft function in kidney transplant recipients.

Authors:  Valeria R Mas; Kellie J Archer; Mariano Scian; Daniel G Maluf
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

6.  RNA expression profiling of renal allografts in a nonhuman primate identifies variation in NK and endothelial gene expression.

Authors:  R N Smith; B A Adam; I A Rosales; M Matsunami; T Oura; A B Cosimi; T Kawai; M Mengel; R B Colvin
Journal:  Am J Transplant       Date:  2018-02-02       Impact factor: 8.086

7.  RNA expression profiling of nonhuman primate renal allograft rejection identifies tolerance.

Authors:  R N Smith; M Matsunami; B A Adam; I A Rosales; T Oura; A B Cosimi; T Kawai; M Mengel; R B Colvin
Journal:  Am J Transplant       Date:  2018-02-17       Impact factor: 8.086

8.  MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA.

Authors:  M J Scian; D G Maluf; K G David; K J Archer; J L Suh; A R Wolen; M U Mba; H D Massey; A L King; T Gehr; A Cotterell; M Posner; V Mas
Journal:  Am J Transplant       Date:  2011-07-27       Impact factor: 8.086

Review 9.  Kidney Fibrosis: Origins and Interventions.

Authors:  Thomas Vanhove; Roel Goldschmeding; Dirk Kuypers
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

Review 10.  Kidney allograft fibrosis: what we learned from latest translational research studies.

Authors:  Simona Granata; Claudia Benedetti; Giovanni Gambaro; Gianluigi Zaza
Journal:  J Nephrol       Date:  2020-03-19       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.